Location History:
- Cambridge, GB (2010 - 2022)
- Haverhill Suffolk, GB (2022)
Company Filing History:
2 out of 2 
2 out of 38 
1 out of 4 Years Active: 2010-2022
Title: The Innovative Contributions of Peter Richardson
Introduction
Peter Richardson is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in cancer therapies. With a total of five patents to his name, Richardson's work focuses on innovative drug combinations aimed at treating various forms of cancer.
Latest Patents
Richardson's latest patents include groundbreaking inventions such as a drug combination that utilizes a CXCR4 antagonist and an immune checkpoint inhibitor. This combination is designed for the treatment of tumors and cancers. Another significant patent involves the use of a specific compound for treating central nervous system (CNS) cancers, along with combination treatments that incorporate irradiation and chemotherapeutic agents.
Career Highlights
Throughout his career, Peter Richardson has worked with several prominent companies, including Cambridge Biotechnology Ltd and Proximagen Limited. His experience in these organizations has allowed him to develop and refine his innovative ideas in the biotechnology sector.
Collaborations
Richardson has collaborated with notable colleagues such as Kevin Lee and Lisa Lione. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.
Conclusion
Peter Richardson's contributions to cancer therapy through his innovative patents highlight his dedication to improving medical treatments. His work continues to influence the field of biotechnology and offers hope for better therapeutic options for cancer patients.